01:15:09 EDT Fri 10 Oct 2025
Enter Symbol
or Name
USA
CA



Bausch Health Companies Inc
Symbol BHC
Shares Issued 370,126,021
Close 2025-10-08 C$ 8.88
Market Cap C$ 3,286,719,066
Recent Sedar Documents

Bausch Health holders OK amended holder rights plan

2025-10-09 12:40 ET - News Release

An anonymous director reports

BAUSCH HEALTH ANNOUNCES RESULTS OF SPECIAL MEETING OF SHAREHOLDERS

Bausch Health Companies Inc. has released the results of the special meeting of shareholders held on Oct. 7, 2025. At the shareholders meeting, shareholders of the company approved the ratification, confirmation and approval of the adoption of the company's amended and restated shareholder rights plan agreement dated April 14, 2025, as amended and restated on Aug. 25, 2025, as described in detail in the company's management proxy circular and proxy statement dated Aug. 27, 2025.

The final vote tabulation for the matter voted on at the shareholders meeting will be reported to the United States Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the company's SEDAR+ profile and on the company's website.

About Bausch Health Companies Inc.

Bausch Health is a global diversified pharmaceutical company enriching lives through the company's relentless drive to deliver better health care outcomes. The company develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through the company's controlling interest in Bausch + Lomb. The company's ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.